These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 10213494

  • 1. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 15; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 3. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
    Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S.
    Cancer Res; 1992 Aug 15; 52(16):4413-9. PubMed ID: 1386556
    [Abstract] [Full Text] [Related]

  • 4. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 15; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 5. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
    Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M.
    Nat Genet; 2000 Jul 15; 25(3):329-32. PubMed ID: 10888884
    [Abstract] [Full Text] [Related]

  • 6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 7. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
    Cui XS, Donehower LA.
    Oncogene; 2000 Dec 07; 19(52):5988-96. PubMed ID: 11146550
    [Abstract] [Full Text] [Related]

  • 8. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
    Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T, Varmus HE, Donehower LA.
    Cell Growth Differ; 1997 Aug 07; 8(8):829-38. PubMed ID: 9269892
    [Abstract] [Full Text] [Related]

  • 9. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 10. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX, Papkoff J, Sarkar NH.
    Virology; 1999 Mar 01; 255(1):138-49. PubMed ID: 10049829
    [Abstract] [Full Text] [Related]

  • 11. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P, Korach KS.
    Cancer Res; 2002 May 15; 62(10):2798-805. PubMed ID: 12019156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
    Edwards PA, Hiby SE, Papkoff J, Bradbury JM.
    Oncogene; 1992 Oct 15; 7(10):2041-51. PubMed ID: 1408145
    [Abstract] [Full Text] [Related]

  • 14. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 15. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 16. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
    Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS.
    Oncogene; 2005 Jun 09; 24(25):4094-105. PubMed ID: 15897912
    [Abstract] [Full Text] [Related]

  • 17. Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse.
    Marino S, Romelfanger C, Yokota Y, Nusse R.
    BMC Cancer; 2004 Dec 15; 4():91. PubMed ID: 15601467
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM, Welsh J.
    Carcinogenesis; 2004 Dec 15; 25(12):2361-72. PubMed ID: 15333467
    [Abstract] [Full Text] [Related]

  • 19. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
    Devanesan P, Santen RJ, Bocchinfuso WP, Korach KS, Rogan EG, Cavalieri E.
    Carcinogenesis; 2001 Sep 15; 22(9):1573-6. PubMed ID: 11532882
    [Abstract] [Full Text] [Related]

  • 20. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA.
    Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.